PMID- 17525224 OWN - NLM STAT- MEDLINE DCOM- 20070702 LR - 20181113 IS - 0146-0404 (Print) IS - 0146-0404 (Linking) VI - 48 IP - 6 DP - 2007 Jun TI - Paradoxical role of BDNF: BDNF+/- retinas are protected against light damage-mediated stress. PG - 2877-86 AB - PURPOSE: Photoreceptors can be prevented from undergoing apoptosis in response to constant light by the application of exogenous neuroprotective agents, including brain-derived neurotrophic factor (BDNF). BDNF, however, cannot exert its effect directly on photoreceptors because they do not express receptors for BDNF. It has been proposed that BDNF released from Muller cells provides a feed-forward loop, increasing ciliary neurotrophic factor (CNTF) and basic fibroblast growth factor (bFGF) production in Muller cells, which may enhance photoreceptor survival. The authors hypothesized that retinas with reduced BDNF levels in which the BDNF-mediated release of neuroprotective signals is dampened are more susceptible to light-induced photoreceptor degeneration. METHODS: Young adult BDNF+/+ and BDNF+/- littermates (B6.129-BDNF(tm1-LT)) were analyzed. Retinal neurotrophin and growth factor mRNA levels were determined by quantitative RT-PCR, photoreceptor function was assessed through electroretinography, and survival was documented in morphologic sections and in TUNEL assays. Oxidative stress was assayed by measuring glutathione peroxidase activity. RESULTS: At baseline, BDNF+/- animals had significantly increased levels of glial-derived neurotrophic factor (GDNF) mRNA compared with their wild-type littermates. After light damage GDNF, CNTF, and BDNF mRNA levels dropped 14- to 16-fold in the BDNF+/+ mice but remained almost unchanged compared with baseline levels in the BDNF+/- mice. Preservation of neurotrophin levels in BDNF+/- mice correlated with photoreceptor cell survival, preservation of function, and reduced oxidative stress. CONCLUSIONS: Contrary to the hypothesis, reducing BDNF levels resulted in photoreceptor protection against light damage. Survival was paralleled by a reduction in oxidative stress and the preservation of neurotrophin levels, suggesting that chronic reduction of BDNF in the retina provides a level of preconditioning against stress. FAU - Wilson, R Brooks AU - Wilson RB AD - Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina 29425, USA. FAU - Kunchithapautham, Kannan AU - Kunchithapautham K FAU - Rohrer, Barbel AU - Rohrer B LA - eng GR - EY-13520/EY/NEI NIH HHS/United States GR - EY-14793/EY/NEI NIH HHS/United States GR - R24 EY014793/EY/NEI NIH HHS/United States GR - R01 EY013520-04S1/EY/NEI NIH HHS/United States GR - AG-23630/AG/NIA NIH HHS/United States GR - P01 AG023630-029001/AG/NIA NIH HHS/United States GR - P01 AG023630/AG/NIA NIH HHS/United States GR - R01 EY013520-04/EY/NEI NIH HHS/United States GR - R01 EY013520/EY/NEI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Ciliary Neurotrophic Factor) RN - 0 (Glial Cell Line-Derived Neurotrophic Factor) RN - 0 (Nerve Growth Factors) RN - 0 (RNA, Messenger) RN - EC 1.11.1.9 (Glutathione Peroxidase) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/*physiology MH - Cell Survival MH - Ciliary Neurotrophic Factor/genetics MH - Electroretinography MH - Female MH - Glial Cell Line-Derived Neurotrophic Factor/genetics MH - Glutathione Peroxidase/metabolism MH - In Situ Nick-End Labeling MH - Light/adverse effects MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Nerve Growth Factors/genetics MH - *Oxidative Stress MH - RNA, Messenger/metabolism MH - Radiation Injuries, Experimental/metabolism/pathology/*prevention & control MH - Retina/*radiation effects MH - Retinal Degeneration/metabolism/pathology/*prevention & control MH - Reverse Transcriptase Polymerase Chain Reaction PMC - PMC1964504 MID - NIHMS24415 EDAT- 2007/05/26 09:00 MHDA- 2007/07/03 09:00 PMCR- 2008/06/01 CRDT- 2007/05/26 09:00 PHST- 2007/05/26 09:00 [pubmed] PHST- 2007/07/03 09:00 [medline] PHST- 2007/05/26 09:00 [entrez] PHST- 2008/06/01 00:00 [pmc-release] AID - 48/6/2877 [pii] AID - 10.1167/iovs.06-1079 [doi] PST - ppublish SO - Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2877-86. doi: 10.1167/iovs.06-1079.